The Journal of Urology
Volume 182, Issue 1 , Pages 21-28 , July 2009

Maintaining a Sterile Urinary Tract: The Role of Antimicrobial Peptides

  • Ased S.M. Ali
    • ,
  • Claire L. Townes
    • ,
  • Judith Hall
    • ,
  • Robert S. Pickard

      Affiliations

    • Corresponding Author InformationCorrespondence: Surgical and Reproductive Sciences (SARS), Faculty of Medical Sciences, 3rd Floor, William Leech Building, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, United Kingdom (telephone: +44 (0)191 2137139; FAX: +44 (0)191 2137127)

Received 30 October 2008

References 

  1. Kucheria R, Dasgupta P, Sacks SH, Khan MS, Sheerin NS. Urinary tract infections: new insights into a common problem. Postgrad Med J. 2005;81:83
  2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002;113(suppl.):5S
  3. Franco AV. Recurrent urinary tract infections. Best Pract Res Clin Obstet Gynaecol. 2005;19:861
  4. Stapleton A. Prevention of recurrent urinary-tract infections in women. Lancet. 1999;353:7
  5. Zaiou M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med. 2007;85:317
  6. Tytler EM, Anantharamaiah GM, Walker DE, Mishra VK, Palgunachari MN, Segrest JP. Molecular basis for prokaryotic specificity of magainin-induced lysis. Biochemistry. 1995;34:4393
  7. Ludtke SJ, He K, Heller WT, Harroun TA, Yang L, Huang HW. Membrane pores induced by magainins. Biochemistry. 1996;35:13723
  8. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta. 1999;1462:55
  9. Mor A. Peptide-based antibiotics: a potential answer to raging antimicrobial resistance. Drug Dev Res. 2000;50:440
  10. Wieprecht T, Dathe M, Beyermann M, Krause E, Maloy WL, MacDonald DL, et al. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry. 1997;36:6124
  11. Matsuzaki K, Sugislita K, Ishibe N, Ueha M, Nakata S, Miyajima K, et al. Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry. 1998;37:11856
  12. Dagan A, Efron L, Gaidukov L, Mor A, Ginsburg H. In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob Agents Chemother. 2002;46:1059
  13. Matsuzaki K, Sugishita K, Harada M, Fujii N, Miyajima K. Interactions of an antimicrobial peptide, magainin-2, with outer and inner membranes of gram-negative bacteria. Biochim Biophys Acta. 1997;1327:119
  14. Tossi A, Sandri L, Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers. 2000;55:4
  15. Peschel A, Sahl HG. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol. 2006;4:529
  16. Tikhonov I, Rebenok A, Chyzh A. A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis. Nephrol Dial Transplant. 1997;12:2557
  17. Bevins CL. Paneth cell defensins: key effector molecules of innate immunity. Biochem Soc Trans. 2006;34:263
  18. Wiechula BE, Friedek DA, Ekiel AM, Romanik MK, Martirosian G. Human neutrophil peptides in vaginitis/cervicitis of different etiology. Pol J Microbiol. 2007;56:185
  19. Quayle AJ, Porter EM, Nussbaum AA, Wang YM, Brabec C, Yip KP, et al. Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol. 1998;152:1247
  20. Ali ASM, Townes CL, Hall J, Pickard RS. Differential expression of the HD5 antimicrobial peptide in the human urinary tract. BJU Int. 2008;101(suppl.):42
  21. Schutte BC, Mitros JP, Bartlett JA, Walters JD, Jia HP, Welsh MJ, et al. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci U S A. 2002;99:2129
  22. Leong WI, Lönnerdal B. Hepcidin, the recently identified peptide that appears to regulate iron absorption. J Nutr. 2004;134:1
  23. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB, Ganz T. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest. 1998;101:1633
  24. Lehmann J, Retz M, Harder J, Krams M, Kellner U, Hartmann J, et al. Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection. BMC Infect Dis. 2002;2:20
  25. Morrison G, Kilanowski F, Davidson D, Dorin J. Characterization of the mouse beta defensin 1, Defb1, mutant mouse model. Infect Immun. 2002;70:3053
  26. Fleming DC, King AE, Williams AR, Critchley HO, Kelly RW. Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium. Fertil Steril. 2003;79:856
  27. King AE, Fleming DC, Critchley HO, Kelly RW. Differential expression of the natural antimicrobials, beta-defensins 3 and 4, in human endometrium. J Reprod Immunol. 2003;59:1
  28. Fellermann K, Stange DE, Schaeffeler E, Schmalzl H, Wehkamp J, Bevins CL, et al. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am J Hum Genet. 2006;79:439
  29. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, et al. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 2000;96:3086
  30. Chromek M, Slamová Z, Bergman P, Kovács L, Podracká L, Ehrén I, et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med. 2006;12:636
  31. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001;276:7806
  32. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480:147
  33. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. 2002;100:3776
  34. Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. Am J Kidney Dis. 2003;42:658
  35. Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int. 2004;65:791
  36. Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, et al. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2006;103:1834
  37. Abrink M, Larsson E, Gobl A, Hellman L. Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism. Kidney Int. 2000;57:2004
  38. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005;17:1
  39. Hoskin DW, Ramamoorthy A. Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta. 2008;1778:357
  40. www.migenix.com/prod_226.html. Accessed February 11, 2009.
  41. Ballweber LM, Jaynes JE, Stamm WE, Lampe MF. In vitro microbicidal activitites of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis. Antimicrob Agents Chemother. 2002;46:34
  42. Haversen LA, Engberg I, Baltzer L, Dolphin G, Hanson LA, Mattsby-Baltzer I. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun. 2000;68:5816
  43. Zasloff M. Defending the epithelium. Nat Med. 2006;12:607
  44. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909
  45. Schauber J, Svanholm C, Termen S, Iffland K, Menzel T, Scheppach W, et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut. 2003;52:735
  46. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25dihydroxyvitamin D3. FASEB J. 2005;19:1067
  47. Bland R, Zehnder D, Hughes SV, Ronco PM, Stewart PM, Hewison M. Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line. Kidney Int. 2001;60:1277
  48. Raqib R, Sarker P, Bergman P, Ara G, Lindh M, Sack DA, et al. Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic. Proc Natl Acad Sci U S A. 2006;103:9178
  49. Schumm K, Lam TB, et al. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2008;CD004013

PII: S0022-5347(09)00545-X

doi: 10.1016/j.juro.2009.02.124

The Journal of Urology
Volume 182, Issue 1 , Pages 21-28 , July 2009

Article Tools

* Image Usage & Resolution